Press Release FeedGet the RSS feed
Menu

Business Wire

Valerio Therapeutics and Etherna Immunotherapies Progress Towards Finalisation of Transaction Documentation Regarding the Contemplated Acquisition

Business Wire

VILLEJUIF, France, August 17, 2026--Regulatory News:

Valerio Therapeutics (FR0010095596 - ALVIO), a biotechnology company pioneering next-generation precision-guided RNA therapeutics ("Valerio" or the "Company"), provides an update on the contemplated acquisition of 100% of the share capital of Etherna Immunotherapies NV ("Etherna") (the "Acquisition").

On July 1, 2026, Valerio announced the submission of a binding offer for the Acquisition on the basis of an enterprise value of EUR 30 million. In connection with the binding offer, Valerio and Etherna had initially agreed to a six-week exclusivity period to finalise the definitive transaction documentation.

Since that announcement, the parties have made substantial progress towards the contemplated Acquisition, including the receipt of the required foreign direct investment clearance. Valerio has agreed to continue the constructive discussions with Etherna to work towards finalising the definitive agreements, with a view to signing the Acquisition by August 21, 2026.

The Company will keep the market informed of further developments in accordance with its applicable disclosure obligations.

About Valerio Therapeutics

Valerio Therapeutics (FR0010095596 – ALVIO) is a pioneering biotechnology company specialized in the discovery and development of innovative targeted RNA therapeutics. The Company is listed on Euronext Growth Paris.

For more information: https://valeriotx.com/.

Forward-Looking Statements

This press release contains certain forward-looking statements regarding Valerio Therapeutics and its activities, including statements regarding the expected completion of the Acquisition. These forward-looking statements are based on assumptions that Valerio Therapeutics considers to be reasonable. However, there can be no assurance that these forward-looking statements will prove to be accurate or that the Acquisition will be completed on the terms contemplated or at all, as these statements are subject to numerous risks, including those set out in the 2025 annual financial report published on April 28, 2026, and available on the Valerio Therapeutics website, as well as changes in the economic environment, financial markets and the markets in which Valerio Therapeutics operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Valerio Therapeutics or not currently considered material by Valerio Therapeutics. The occurrence of all or part of these risks could cause actual results, financial condition, performance or achievements of Valerio Therapeutics to differ materially from these forward-looking statements. This press release and the information contained herein do not constitute an offer to sell or subscribe for, or a solicitation of an offer to purchase or subscribe for, shares of Valerio Therapeutics in any country. The distribution of this press release in certain countries may constitute a violation of local laws and regulations. Any recipient of this press release must inform themselves of and comply with such local restrictions.

  1. FinanceCushman & WakefieldCushman & Wakefield Strengthens Chicago Office Leasing and Capital Markets Teams with Addition of Peter Adamo, Adam Lawler and Madeline LelandAdam Lawler Trio brings extensive experience advising owners and investors across Chicago's suburban office market and will provide leasing and capital markets advisory services CHICAGO, October 22, 2026--Cushman & Wakefield (NYSE: CWK), a leading global real estate services firm, today announced the a
  2. EducationThe Connellsville Area School DistrictConnellsville Area School District Kicks Off Major Infrastructure Modernization Project at District’s Largest Elementary SchoolConnellsville Area School District marks the start of a major modernization of Dunbar Township Elementary School, including a new community-championed inclusive playground designed to create greater opportunities for students of all abilities to play and connect. The comprehensive project represents the first major renova
  3. ComEd, Metropolitan Mayors Caucus Help Make Spirits Bright this Season with 28 Grants to Power Holiday Light EventsSixth annual Powering the Holidays Grant Program provides $69,500 to support decoration and lighting projects in northern Illinois communities CHICAGO, October 22, 2026--With the holiday season just around the corner, ComEd and the Metropolitan Mayors Caucus are brightening communities across northern
  4. HealthcareNFL Biosciences Reports Its 2026 Half-Year Results and Progress With Its Two Immunotherapies for Smoking and Nicotine CessationNFL-101 – immunotherapy aimed at reducing neuroinflammation: Biomarker results supporting a personalized medicine approach Next step: discussions with the FDA and EMA to confirm the Phase 3 clinical development plan NFL-102 – immunotherapy aimed at restoring neuroplasticity Successful manufacturing of a GMP-compliant clin
  5. InsuranceAM Best Maintains Under Review With Negative Implications Status for Bao Minh Insurance CorporationSINGAPORE, October 22, 2026--AM Best has maintained the under review with negative implications status for the Financial Strength Rating of B++ (Good), the Long-Term Issuer Credit Rating of "bbb" (Good) and the Vietnam National Scale Rating of aaa.VN (Exceptional) of Bao Minh Insurance Corporation (BM
  6. EnergyCore Development GroupCore Development Group Marks 15-Year Anniversary as a National Leader in Energy SolutionsNJ-based energy contractor is driving the future of clean energy infrastructure across the U.S. MAHWAH, N.J., October 22, 2026--Core Development Group , a leading energy Engineering, Procurement, and Construction (EPC) contractor, celebrates 15 years in business and a strong history of constructing re